Late-rising CD4 T cells resolve mouse cytomegalovirus persistent replication in the salivary gland.

Autor: Brunel S; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Picarda G; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Gupta A; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America.; Division of Immune Regulation, La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Ghosh R; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., McDonald B; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., El Morabiti R; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Jiang W; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Greenbaum JA; LJI Bioinformatics Core, La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Adler B; Max von Pettenkofer Institute & Gene Center, Virology, Faculty of Medicine, Ludwig- Maximilians-University Munich, Munich, Germany., Seumois G; Center for Cancer Immunotherapy, Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Croft M; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Vijayanand P; Center for Cancer Immunotherapy, Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America., Benedict CA; Center for Infectious Disease and Vaccine Research, Center for Autoimmunity and Inflammation La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2024 Jan 18; Vol. 20 (1), pp. e1011852. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).

Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames.

Autor: Dhanwani R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Dhanda SK; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Pham J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Williams GP; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Sidney J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Picarda G; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, California, USA., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA., Benedict CA; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, California, USA.

Publikováno v: Journal of virology [J Virol] 2021 Oct 13; Vol. 95 (21), pp. e0094021. Date of Electronic Publication: 2021 Aug 11.

Osteoprotegerin inhibits bone resorption and prevents tumor\ud development in a xenogenic model of Ewing's sarcoma by\ud inhibiting RANKL

Autor: Picarda, G., Matous, E., Amiaud, J., Charrier, C., Lamoureux, F., Heymann, M-F., Tirode, F., Pitard, B., Trichet, V., Heymann, D., Redini, F.

Ewing's sarcoma (ES) associated with high osyeolytic lesions typically arises in the bones of children and\ud adolescents. The development of multi-disciplinary therapy has increased current long-term survival rates to\ud greater than 50% but only 20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f0f326097dad83f7a7b03f129e2cf932

DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8⁺ T cells.

Autor: Yu, Zheng¹ (AUTHOR), Sasidharan-Nair, Varun¹ (AUTHOR), Buchta, Thalea^2,3 (AUTHOR), Bonifacius, Agnes^4,5 (AUTHOR), Khan, Fawad^6,7 (AUTHOR), Pietzsch, Beate¹ (AUTHOR), Ahmadi, Hosein¹ (AUTHOR), Beckstette, Michael¹ (AUTHOR), Niemz, Jana¹ (AUTHOR), Hilgendorf, Philipp⁸ (AUTHOR), Mausberg, Philip⁴ (AUTHOR), Keller, Andreas^9,10 (AUTHOR), Falk, Christine^5,11 (AUTHOR), Busch, Dirk H.^12,13 (AUTHOR), Schober, Kilian^8,14 (AUTHOR), Cicin-Sain, Luka^5,6,7 (AUTHOR), Müller, Fabian¹⁵ (AUTHOR), Brinkmann, Melanie M.^2,3 (AUTHOR), Eiz-Vesper, Britta^4,5 (AUTHOR), Floess, Stefan¹ (AUTHOR)

Publikováno v: PLoS Pathogens. 9/26/2024, Vol. 20 Issue 9, p1-30. 30p.

Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator.

Autor: Bitra A; From the Division of Immune Regulation, La Jolla Institute for Immunology, La Jolla, California 92037., Nemčovičová I; the Biomedical Research Center, Slovak Academy of Sciences, SK 84505 Bratislava, Slovakia., Picarda G; From the Division of Immune Regulation, La Jolla Institute for Immunology, La Jolla, California 92037., Doukov T; the Stanford Synchrotron Radiation Lightsource, SLAC, Menlo Park, California 94025, and., Wang J; From the Division of Immune Regulation, La Jolla Institute for Immunology, La Jolla, California 92037., Benedict CA; From the Division of Immune Regulation, La Jolla Institute for Immunology, La Jolla, California 92037., Zajonc DM; From the Division of Immune Regulation, La Jolla Institute for Immunology, La Jolla, California 92037, Dirk.Zajonc@pfizer.com.; the Department of Internal Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.

Publikováno v: The Journal of biological chemistry [J Biol Chem] 2019 Jul 05; Vol. 294 (27), pp. 10519-10529. Date of Electronic Publication: 2019 May 24.